P.V. Ramprasad Reddy

P.V. Ramprasad Reddy sits on the board of generics maker Aurobindo Pharma, which he cofounded in 1986.

Aurobindo Pharma makes drugs to treat a range of diseases such as diabetes and cardiac ailments.

The company gets nearly three-fourths of its revenue from the U.S. and Europe.

Starting with a single manufacturing plant, Aurobindo expanded into a global company with 35 manufacturing plants and 9 R&D Centers that serve more than 150 countries.

In July 2025, Aurobindo struck a $250 million deal to acquire U.S. drugmaker Lannett to expand its American manufacturing footprint.